×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
复旦大学上海医学院 [13]
中国医学科学院 北... [10]
中南大学 [5]
四川大学 [2]
合肥物质科学研究院 [2]
山东大学 [1]
更多...
内容类型
期刊论文 [33]
会议论文 [6]
发表日期
2021 [1]
2019 [2]
2018 [10]
2017 [3]
2016 [3]
2015 [6]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共39条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
A Support Vector Machine Based on Liquid Immune Profiling Predicts Major Pathological Response to Chemotherapy Plus Anti-PD-1/PD-L1 as a Neoadjuvant Treatment for Patients With Resectable Non-Small Cell Lung Cancer
期刊论文
FRONTIERS IN IMMUNOLOGY, 2021, 卷号: 12
作者:
Peng, Jie
;
Zou, Dan
;
Han, Lijie
;
Yin, Zuomin
;
Hu, Xiao
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2022/02/14
non-small cell lung cancer
support vector machine
major pathological response
liquid immune profiling
neoadjuvant treatment
A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy Versus Chemotherapy Alone for Advanced Nonsquamous Non-Small-Cell Lung Cancer in China.
期刊论文
Value in health regional issues, 2019, 卷号: 18
作者:
Li Xinyan
;
Li Weichen
;
Hou Lingping
收藏
  |  
浏览/下载:12/0
  |  
提交时间:2019/12/05
bevacizumab
chemotherapy
cost-effectiveness
non–small-cell lung cancer
Comparative Effectiveness of Pemetrexed-platinum Doublet Chemotherapy With or Without Bevacizumab as First-line Therapy for Treatment-naive Patients With Advanced Nonsquamous Non–small-cell Lung Cancer in China
期刊论文
Clinical Therapeutics, 2019
作者:
Xiaoyou Li
;
Muhammad Abbas
;
Yun Li
;
Yue Teng
;
Ying Fang
收藏
  |  
浏览/下载:16/0
  |  
提交时间:2019/12/17
bevacizumab
brain metastasis
maintenance therapy
nonsquamous non–small-cell lung cancer (NS-NSCLC)
pemetrexed-platinum doublet
pleural effusion
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 12
作者:
Yang, Jin-ji
;
Zhou, Jianying
;
Wang, Jie
;
An, Tongtong
;
Yang, Lei
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer (CTONG1506)
会议论文
作者:
Yu, P.
;
Zhou, Q.
;
Song, Y.
;
Zhang, X.
;
Chen, G.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
NSCLC
real world
survival
Factors associated with gene aberration test status and treatment decision in patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer: A multicenter survey in China (CTONG 1506)
期刊论文
LUNG CANCER, 2018, 卷号: 123
作者:
Song, Yong
;
Zhou, Qing
;
Zhang, Xin
;
Chen, Gong-Yan
;
Zhong, Dian-Sheng
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2019/12/05
Nonsquamous non-small cell lung cancer
Gene aberration test
First-line anticancer treatment
Real-world research
Tyrosine kinase inhibitor
Chemotherapy
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: 36, 期号: 12
作者:
Lu, Shun
;
Chang, Jianhua
;
Liu, Xiaoqing
;
Shi, Jianhua
;
Lu, You
收藏
  |  
浏览/下载:6/0
  |  
提交时间:2019/12/05
A Multicenter Survey of One Year Survival Among Chinese Patients with Advanced Nonsquamous NonSmall Cell Lung Cancer (CTONG1506)
会议论文
作者:
Yu, P.
;
Zhou, Q.
;
Song, Y.
;
Zhang, X.
;
Chen, G.
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2019/12/05
Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Fruquintinib After Two Prior Chemotherapy Regimens in Chinese Patients With Advanced Nonsquamous NonSmall-Cell Lung Cancer
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2018, 卷号: Vol.36 No.12, 页码: 1207
作者:
Lu, S
;
Chang, JH
;
Liu, XQ
;
Shi, JH
;
Lu, Y
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/02/25
A Trial-Based Cost-Effectiveness Analysis of Bevacizumab and Chemotherapy versus Chemotherapy Alone for Advanced Nonsquamous Non-Small-Cell Lung Cancer in China
期刊论文
Value in health regional issues, 2018, 卷号: 18, 页码: 1-7
作者:
Li Xinyan[1]
;
Li Weichen[2]
;
Hou Lingping[3]
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/04/22
bevacizumab
chemotherapy
cost-effectiveness
non–small-cell lung cancer
©版权所有 ©2017 CSpace - Powered by
CSpace